FDA Inspection 1241466 — Rukan Daccak, M.D.
The FDA completed an inspection of Rukan Daccak, M.D. on May 8, 2024 in Pasadena, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 8, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Pasadena, TX (United States)
Additional Details
Clinical Investigator (CI)